Abstract
Regions of hypoxia in tumours can be modelled in vitro in 2D cell cultures with a hypoxic chamber or incubator in which oxygen levels can be regulated. Although this system is useful in many respects, it disregards the additional physiological gradients of the hypoxic microenvironment, which result in reduced nutrients and more acidic pH. Another approach to hypoxia modelling is to use three-dimensional spheroid cultures. In spheroids, the physiological gradients of the hypoxic tumour microenvironment can be inexpensively modelled and explored. In addition, spheroids offer the advantage of more representative modelling of tumour therapy responses compared with 2D culture. Here, we review the use of spheroids in hypoxia tumour biology research and highlight the different methodologies for spheroid formation and how to obtain uniformity. We explore the challenge of spheroid analyses and how to determine the effect on the hypoxic versus normoxic components of spheroids. We discuss the use of high-throughput analyses in hypoxia screening of spheroids. Furthermore, we examine the use of mathematical modelling of spheroids to understand more fully the hypoxic tumour microenvironment.
*These authors contributed equally.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Vaupel P. The role of hypoxia-induced factors in tumor progression. Oncologist. 2004;9(Suppl):510–7.
Choudhry H, Schodel J, Oikonomopoulos S, et al. Extensive regulation of the non-coding transcriptome by hypoxia: role of HIF in releasing paused RNApol2. EMBO Rep. 2014;15(1):70–6.
Semenza GL. Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology. Annu Rev Pathol. 2014;9:947–71.
Harris AL. Hypoxia—a key regulatory factor in tumour growth. Nat Rev Cancer. 2002;2(1):38–47.
Rebucci M, Michiels C. Molecular aspects of cancer cell resistance to chemotherapy. Biochem Pharmacol. 2013;85(9):1219–26.
Multhoff G, Radons J, Vaupel P. Critical role of aberrant angiogenesis in the development of tumor hypoxia and associated radioresistance. Cancers (Basel). 2014;6(2):813–28.
McIntyre A, Harris AL. Metabolic and hypoxic adaptation to anti-angiogenic therapy: a target for induced essentiality. EMBO Mol Med. 2015;7(4):368–79.
Hirschhaeuser F, Menne H, Dittfeld C, et al. Multicellular tumor spheroids: an underestimated tool is catching up again. J Biotechnol. 2010;148(1):3–15.
McIntyre A, Patiar S, Wigfield S, et al. Carbonic anhydrase IX promotes tumor growth and necrosis in vivo and inhibition enhances anti-VEGF therapy. Clin Cancer Res. 2012;18(11):3100–11.
Minchinton AI, Tannock IF. Drug penetration in solid tumours. Nat Rev Cancer. 2006;6(8):583–92.
Bingle L, Lewis CE, Corke KP, et al. Macrophages promote angiogenesis in human breast tumour spheroids in vivo. Br J Cancer. 2006;94(1):101–7.
Ivanov DP, Parker TL, Walker DA, et al. In vitro co-culture model of medulloblastoma and human neural stem cells for drug delivery assessment. J Biotechnol. 2015;205:3–13.
Dolznig H, Rupp C, Puri C, et al. Modeling colon adenocarcinomas in vitro a 3D co-culture system induces cancer-relevant pathways upon tumor cell and stromal fibroblast interaction. Am J Pathol. 2011;179(1):487–501.
Tang XH, Lucas JE, Chen JLY, et al. Functional interaction between responses to lactic acidosis and hypoxia regulates genomic transcriptional outputs. Cancer Res. 2012;72(2):491–502.
Ellingsen C, Walenta S, Hompland T, et al. The microenvironment of cervical carcinoma xenografts: associations with lymph node metastasis and its assessment by DCE-MRI. Transl Oncol. 2013;6(5):607–17.
Grimshaw MJ, Cooper L, Papazisis K, et al. Mammosphere culture of metastatic breast cancer cells enriches for tumorigenic breast cancer cells. Breast Cancer Res. 2008;10(3):R52.
Koo BK, Stange DE, Sato T, et al. Controlled gene expression in primary Lgr5 organoid cultures. Nat Methods. 2012;9(1):81–3.
Ivascu A, Kubbies M. Rapid generation of single-tumor spheroids for high-throughput cell function and toxicity analysis. J Biomol Screen. 2006;11(8):922–32.
Fennema E, Rivron N, Rouwkema J, et al. Spheroid culture as a tool for creating 3D complex tissues. Trends Biotechnol. 2013;31(2):108–15.
Leek RD, Stratford I, Harris AL. The role of hypoxia-inducible factor-1 in three-dimensional tumor growth, apoptosis, and regulation by the insulin-signaling pathway. Cancer Res. 2005;65(10):4147–52.
Friedrich J, Ebner R, Kunz-Schughart LA. Experimental anti-tumor therapy in 3-D: spheroids—old hat or new challenge? Int J Radiat Biol. 2007;83(11-12):849–71.
Timmins NE, Nielsen LK. Generation of multicellular tumor spheroids by the hanging-drop method. Methods Mol Med. 2007;140:141–51.
Kelm JM, Timmins NE, Brown CJ, et al. Method for generation of homogeneous multicellular tumor spheroids applicable to a wide variety of cell types. Biotechnol Bioeng. 2003;83(2):173–80.
Hsiao AY, Tung YC, Qu X, et al. 384 hanging drop arrays give excellent Z-factors and allow versatile formation of co-culture spheroids. Biotechnol Bioeng. 2012;109(5):1293–304.
Napolitano AP, Chai P, Dean DM, et al. Dynamics of the self-assembly of complex cellular aggregates on micromolded nonadhesive hydrogels. Tissue Eng. 2007;13(8):2087–94.
Shimizu K, Kusamori K, Nishikawa M, et al. Poly(N-isopropylacrylamide)-coated microwell arrays for construction and recovery of multicellular spheroids. J Biosci Bioeng. 2013;115(6):695–9.
Torisawa YS, Chueh BH, Huh D, et al. Efficient formation of uniform-sized embryoid bodies using a compartmentalized microchannel device. Lab Chip. 2007;7(6):770–6.
Wu LY, Di Carlo D, Lee LP. Microfluidic self-assembly of tumor spheroids for anticancer drug discovery. Biomed Microdevices. 2008;10(2):197–202.
Torisawa YS, Takagi A, Nashimoto Y, et al. A multicellular spheroid array to realize spheroid formation, culture, and viability assay on a chip. Biomaterials. 2007;28(3):559–66.
Yoshii Y, Waki A, Yoshida K, et al. The use of nanoimprinted scaffolds as 3D culture models to facilitate spontaneous tumor cell migration and well-regulated spheroid formation. Biomaterials. 2011;32(26):6052–8.
Yoshii Y, Furukawa T, Waki A, et al. High-throughput screening with nanoimprinting 3D culture for efficient drug development by mimicking the tumor environment. Biomaterials. 2015;51:278–89.
Tofilon PJ, Arundel CM, Deen DF. Response to BCNU of spheroids grown from mixtures of drug-sensitive and drug-resistant cells. Cancer Chemother Pharmacol. 1987;20(2):89–95.
Djordjevic B, Lange CS. Cell-cell interactions in spheroids maintained in suspension. Acta Oncol. 2006;45(4):412–20.
Hauptmann S, Zwadlo-Klarwasser G, Jansen M, et al. Macrophages and multicellular tumor spheroids in co-culture: a three-dimensional model to study tumor-host interactions. Evidence for macrophage-mediated tumor cell proliferation and migration. Am J Pathol. 1993;143(5):1406–15.
Gottfried E, Kunz-Schughart LA, Andreesen R, et al. Brave little world: spheroids as an in vitro model to study tumor-immune-cell interactions. Cell Cycle. 2006;5(7):691–5.
Timmins NE, Dietmair S, Nielsen LK. Hanging-drop multicellular spheroids as a model of tumour angiogenesis. Angiogenesis. 2004;7(2):97–103.
Vermeulen S, Van Marck V, Van Hoorde L, et al. Regulation of the invasion suppressor function of the cadherin/catenin complex. Pathol Res Pract. 1996;192(7):694–707.
Offner FA, Schiefer J, Wirtz HC, et al. Tumour-cell-endothelial interactions: free radicals are mediators of melanoma-induced endothelial cell damage. Virchows Arch. 1996;428(2):99–106.
Kunz-Schughart LA, Heyder P, Schroeder J, et al. A heterologous 3-D coculture model of breast tumor cells and fibroblasts to study tumor-associated fibroblast differentiation. Exp Cell Res. 2001;266(1):74–86.
Ivanov DP, Parker TL, Walker DA, et al. Multiplexing spheroid volume, resazurin and acid phosphatase viability assays for high-throughput screening of tumour spheroids and stem cell neurospheres. PLoS One. 2014;9(8), e103817.
Rafajova M, Zatovicova M, Kettmann R, et al. Induction by hypoxia combined with low glucose or low bicarbonate and high posttranslational stability upon reoxygenation contribute to carbonic anhydrase IX expression in cancer cells. Int J Oncol. 2004;24(4):995–1004.
Yakymchuk OM, Perepelytsina OM, Dobrydnev AV, et al. Effect of single-walled carbon nanotubes on tumor cells viability and formation of multicellular tumor spheroids. Nanoscale Res Lett. 2015;10:150.
Friedrich J, Seidel C, Ebner R, et al. Spheroid-based drug screen: considerations and practical approach. Nat Protoc. 2009;4(3):309–24.
Ho WY, Yeap SK, Ho CL, et al. Development of multicellular tumor spheroid (MCTS) culture from breast cancer cell and a high throughput screening method using the MTT assay. PLoS One. 2012;7(9):e44640.
Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65(1-2):55–63.
Abuelba H, Cotrutz CE, Stoica BA, et al. In vitro evaluation of curcumin effects on breast adenocarcinoma 2D and 3D cell cultures. Rom J Morphol Embryol. 2015;56(1):71–6.
Friedrich J, Eder W, Castaneda J, et al. A reliable tool to determine cell viability in complex 3-d culture: the acid phosphatase assay. J Biomol Screen. 2007;12(7):925–37.
Senavirathna LK, Fernando R, Maples D, et al. Tumor SPHEROIDS as an in vitro model for determining the therapeutic response to proton beam radiotherapy and thermally sensitive nanocarriers. Theranostics. 2013;3(9):687–91.
Freyer JP, Sutherland RM. Proliferative and clonogenic heterogeneity of cells from EMT6/Ro multicellular spheroids induced by the glucose and oxygen supply. Cancer Res. 1986;46(7):3513–20.
Roa WH, Miller GG, McEwan AJ, et al. Targeted radiotherapy of multicell neuroblastoma spheroids with high specific activity [125I]meta-iodobenzylguanidine. Int J Radiat Oncol Biol Phys. 1998;41(2):425–32.
Li Q, Chen C, Kapadia A, et al. 3D models of epithelial-mesenchymal transition in breast cancer metastasis: high-throughput screening assay development, validation, and pilot screen. J Biomol Screen. 2011;16(2):141–54.
Wittig R, Richter V, Wittig-Blaich S, et al. Biosensor-expressing spheroid cultures for imaging of drug-induced effects in three dimensions. J Biomol Screen. 2013;18(6):736–43.
Wenzel C, Riefke B, Grundemann S, et al. 3D high-content screening for the identification of compounds that target cells in dormant tumor spheroid regions. Exp Cell Res. 2014;323(1):131–43.
Swietach P, Patiar S, Supuran CT, et al. The role of carbonic anhydrase 9 in regulating extracellular and intracellular ph in three-dimensional tumor cell growths. J Biol Chem. 2009;284(30):20299–310.
Dmitriev RI, Zhdanov AV, Nolan YM, et al. Imaging of neurosphere oxygenation with phosphorescent probes. Biomaterials. 2013;34(37):9307–17.
Zhang S, Hosaka M, Yoshihara T, et al. Phosphorescent light-emitting iridium complexes serve as a hypoxia-sensing probe for tumor imaging in living animals. Cancer Res. 2010;70(11):4490–8.
Kobayashi H, Man S, Graham CH, et al. Acquired multicellular-mediated resistance to alkylating agents in cancer. Proc Natl Acad Sci U S A. 1993;90(8):3294–8.
Abbott A. Cell culture: biology’s new dimension. Nature. 2003;424(6951):870–2.
Herrmann R, Fayad W, Schwarz S, et al. Screening for compounds that induce apoptosis of cancer cells grown as multicellular spheroids. J Biomol Screen. 2008;13(1):1–8.
Mathews LA, Keller JM, Goodwin BL, et al. A 1536-well quantitative high-throughput screen to identify compounds targeting cancer stem cells. J Biomol Screen. 2012;17(9):1231–42.
Kang HJ, Kim IH, Sung CO, et al. Expression of carbonic anhydrase 9 is a novel prognostic marker in resectable hepatocellular carcinoma. Virchows Arch. 2015;466(4):403–13.
Tailor TD, Hanna G, Yarmolenko PS, et al. Effect of pazopanib on tumor microenvironment and liposome delivery. Mol Cancer Ther. 2010;9(6):1798–808.
Snell CE, Turley H, McIntyre A, et al. Proline-hydroxylated hypoxia-inducible factor 1alpha (HIF-1alpha) upregulation in human tumours. PLoS One. 2014;9(2):e88955.
Talks KL, Turley H, Gatter KC, et al. The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages. Am J Pathol. 2000;157(2):411–21.
Durand RE, Raleigh JA. Identification of nonproliferating but viable hypoxic tumor cells in vivo. Cancer Res. 1998;58(16):3547–50.
Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol. 2000;182(3):311–22.
Birner P, Ritzi M, Musahl C, et al. Immunohistochemical detection of cell growth fraction in formalin-fixed and paraffin-embedded murine tissue. Am J Pathol. 2001;158(6):1991–6.
Gown AM, Willingham MC. Improved detection of apoptotic cells in archival paraffin sections: immunohistochemistry using antibodies to cleaved caspase 3. J Histochem Cytochem. 2002;50(4):449–54.
Gray LH, Conger AD, Ebert M, et al. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol. 1953;26(312):638–48.
Hall EJ, Giaccia AJ. Radiobiology for the radiologist. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2006.
Kelly CJ, Hussien K, Muschel RJ. 3D tumour spheroids as a model to assess the suitability of [18F]FDG-PET as an early indicator of response to PI3K inhibition. Nucl Med Biol. 2012;39(7):986–92.
Grimes DR, Kelly C, Bloch K, et al. A method for estimating the oxygen consumption rate in multicellular tumour spheroids. J R Soc Interface. 2014;11(92):20131124.
Burton AC. Rate of growth of solid tumours as a problem of diffusion. Growth. 1966;30(2):157–76.
Boag JW (1977) Oxygen diffusion in tumour capillary networks. Bibl Anat(15 Pt 1):266–9.
Mcelwain DLS, Ponzo PJ. Model for growth of a solid tumor with nonuniform oxygen-consumption. Math Biosci. 1977;35(3-4):267–79.
Marusic M, Bajzer Z, Freyer JP, et al. Analysis of growth of multicellular tumour spheroids by mathematical models. Cell Prolif. 1994;27(2):73–94.
Conger AD, Ziskin MC. Growth of mammalian multicellular tumor spheroids. Cancer Res. 1983;43(2):556–60.
Freyer JP. Role of necrosis in regulating the growth saturation of multicellular spheroids. Cancer Res. 1988;48(9):2432–9.
Steel GG. Growth kinetics of tumours : cell population kinetics in relation to the growth and treatment of cancer. Oxford: Clarendon Press; 1977.
Swan GW. Role of optimal control theory in cancer chemotherapy. Math Biosci. 1990;101(2):237–84.
Wheldon TE. Mathematical models in cancer research. Bristol: Hilger; 1988.
Roose T, Chapman SJ, Maini PK. Mathematical models of avascular tumor growth. SIAM Rev. 2007;49(2):179–208.
Sherratt JA, Chaplain MAJ. A new mathematical model for avascular tumour growth. J Math Biol. 2001;43(4):291–312.
Ward JP, King JR. Mathematical modelling of avascular-tumour growth. IMA J Math Appl Med Biol. 1997;14(1):39–69.
Jones AF, Byrne HM, Gibson JS, et al. A mathematical model of the stress induced during avascular tumour growth. J Math Biol. 2000;40(6):473–99.
Muellerklieser W. Method for the determination of oxygen-consumption rates and diffusion-coefficients in multicellular spheroids. Biophys J. 1984;46(3):343–8.
Koch CJ, Evans SM, Lord EM. Oxygen dependence of cellular uptake of Ef5 [2-(2-Nitro-1h-Imidazol-1-Yl)-N-(2,2,3,3,3-pentafluoropropyl)acetamide]—analysis of drug adducts by fluorescent-antibodies vs bound radioactivity. Br J Cancer. 1995;72(4):869–74.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this paper
Cite this paper
Leek, R., Grimes, D.R., Harris, A.L., McIntyre, A. (2016). Methods: Using Three-Dimensional Culture (Spheroids) as an In Vitro Model of Tumour Hypoxia. In: Koumenis, C., Coussens, L., Giaccia, A., Hammond, E. (eds) Tumor Microenvironment. Advances in Experimental Medicine and Biology, vol 899. Springer, Cham. https://doi.org/10.1007/978-3-319-26666-4_10
Download citation
DOI: https://doi.org/10.1007/978-3-319-26666-4_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-26664-0
Online ISBN: 978-3-319-26666-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)